We could not find any results for:
Make sure your spelling is correct or try broadening your search.
| Ticker | Name | Price | Change | Change % | Volume |
|---|---|---|---|---|---|
KIDZ | Classover Holdings Inc | 1.18 | 0.2102 | 21.67% | 7,413,048 |
MLEC | Moolec Science SA | 9.80 | 1.71 | 21.14% | 138,026 |
GLXG | Galaxy Payroll Group Ltd | 1.40 | 0.1855 | 15.27% | 10,177 |
SANM | Sanmina Corporation | 214.00 | 25.92 | 13.78% | 215,556 |
CTNT | Cheetah Net Supply Chain Service Inc | 0.0309 | 0.0029 | 10.36% | 26,178,820 |
RVMD | Revolution Medicines Inc | 143.70 | 12.03 | 9.14% | 121,084 |
AMOD | Alpha Modus Holdings Inc | 0.3167 | 0.0262 | 9.02% | 14,078 |
MATH | Metalpha Technology Holding Ltd | 1.09 | 0.08 | 7.92% | 104 |
RMSG | Real Messenger Corporation | 1.53 | 0.11 | 7.75% | 806,751 |
OTEX | Open Text Corporation | 24.123 | 1.61 | 7.17% | 585 |
DAIC | CID HoldCo Inc | 0.2099 | 0.0137 | 6.98% | 1,290,423 |
Board of Directors Authorize $600 Million Share Repurchase ProgramSAN JOSE, Calif., April 27, 2026 /PRNewswire/ -- Sanmina Corporation ("Sanmina" or the "Company") (NASDAQ: SANM), a leading integrated manufacturing solutions company, today reported financial results for the second quarter ended March 28, 2026 and outlook for its third fiscal quarter ending June 27, 2026.
Rambus Inc. (NASDAQ:RMBS), a provider of industry-leading chips and IP making data faster and safer, today reported financial results for the first quarter ended March 31, 2026. GAAP revenue for the first quarter was $180.2 million, licensing billings were $70.8 million, product revenue was $88.0 million, and contract and other revenue was $22.6 million. The Company also generated $83.2 million in cash from operating activities in the first quarter.
Financing led by institutional life sciences investor, with participation from new and existing investorsCapital expected to support expansion of CDMO platform and advancement of customer programsJERUSALEM, April 24, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), ("Scinai" or the "Company") a biopharmaceutical company advancing a pipeline of innovative inflammation and immunology therapeutics and the owner of Scinai Biopharma Services Ltd., a contract development and manufacturing organization (CDMO), today announced that it has entered into a securities purchase agreement with an institutional life sciences investor, as well as with new and existing institutional and accredited investors, for the purchase and sale ...
X-energy, Inc. (“X-energy”), a leader in advanced nuclear reactor and fuel technology, today announced the pricing of its upsized initial public offering (“IPO”) of 44,254,659 shares of its Class A common stock at a public offering price of $23.00 per share. In connection with the offering, X-energy has granted the underwriters a 30-day option to purchase up to an additional 6,638,198 shares of Class A common stock.
| Rank | Ticker | Board Name | Posts (24h) |
|---|---|---|---|
| RKT | Rocket Companies Inc | ||
| HIRU | Hiru Corporation | ||
| NB | Niocorp Developments Ltd | ||
| 4 | NLST | NetList Inc | |
| 5 | AMRN | Amarin Corp Plc | |
| 6 | KBLB | Kraig Biocraft Laboratories Inc |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions